honokiol has been researched along with Degenerative Disc Disease in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Fan, SW; Gu, JM; Gu, Y; Hu, ZJ; Huang, KM; Jiang, XS; Jie, ZW; Tang, P; Wang, JY; Xie, ZA | 1 |
| Chen, D; Duan, Y; Hu, J; Huang, C; Huang, Q; Jin, H; Lin, D; Nisar, M; Pan, X; Tian, N; Wang, J; Wang, K; Wang, X; Wu, C; Yan, Y; Zhang, X; Zheng, G | 1 |
2 other study(ies) available for honokiol and Degenerative Disc Disease
| Article | Year |
|---|---|
Honokiol alleviates the degeneration of intervertebral disc via suppressing the activation of TXNIP-NLRP3 inflammasome signal pathway.
Topics: Animals; Antioxidants; Biphenyl Compounds; Carrier Proteins; Cell Cycle Proteins; Inflammasomes; Intervertebral Disc Degeneration; Lignans; Male; NLR Family, Pyrin Domain-Containing 3 Protein; Nucleus Pulposus; Rats; Rats, Sprague-Dawley; Signal Transduction | 2018 |
Small molecule natural compound agonist of SIRT3 as a therapeutic target for the treatment of intervertebral disc degeneration.
Topics: Animals; Antioxidants; Biphenyl Compounds; Cells, Cultured; Female; Humans; Intervertebral Disc Degeneration; Lignans; Male; Middle Aged; Mitochondrial Dynamics; Nucleus Pulposus; Oxidative Stress; Rats; Rats, Sprague-Dawley; Sirtuin 3 | 2018 |